Related Experiment Video
Updated: Oct 15, 2025

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging
Published on: June 29, 2013
Medical Management of Peripheral Artery Disease
Tara A Holder1, J Antonio Gutierrez2, Aaron W Aday3
1Division of Cardiovascular Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, 383 PRB, Nashville, TN 37232-0021, USA. Electronic address: https://twitter.com/TaraHolder17.
Insights
Peripheral artery disease (PAD) management includes lifestyle changes and medications. New antiplatelet and antithrombotic treatments further reduce cardiovascular and limb event risks in PAD patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Peripheral artery disease (PAD) is a common yet undertreated atherosclerotic condition.
- PAD significantly increases morbidity and mortality.
- Optimal medical therapy is crucial for managing PAD patients.
Purpose of the Study:
- To review the essential components of optimal medical therapy for peripheral artery disease.
- To discuss the evidence supporting current and novel therapeutic strategies for PAD.
- To highlight advancements in antiplatelet and antithrombotic treatments for PAD.
Main Methods:
- This review synthesizes data from recent clinical trials and guidelines.
- It focuses on established and emerging pharmacological interventions.
- Evidence for smoking cessation, lipid-lowering, and hypertension treatment is examined.
Main Results:
- Standard therapies include smoking cessation, lipid-lowering, and hypertension control.
- Novel antiplatelet and antithrombotic agents have shown significant benefits.
- These newer therapies reduce the risk of major adverse cardiovascular and limb events.
Conclusions:
- Optimal medical therapy for PAD is multifaceted, combining lifestyle modifications and pharmacotherapy.
- Emerging antiplatelet and antithrombotic therapies represent significant advancements in PAD management.
- Aggressive management of risk factors and utilization of novel therapies are key to improving outcomes in PAD.
Abstract:
Peripheral artery disease is a highly morbid yet undertreated atherosclerotic disease. The cornerstones of peripheral artery disease therapy consist of smoking cessation, lipid-lowering therapy, and hypertension treatment. More recently, clinical trials have demonstrated that novel antiplatelet and antithrombotic therapies reduce the risk of both cardiovascular and limb events in this patient population. In this review, we highlight the components of optimal medical therapy of peripheral artery disease and the evidence base for these therapies.
More Related Videos
14:52Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis IV: Nursing Management
Atherosclerosis III: Management